Luis Malpica1 article listing Luis Malpica in Nature Communications, indexed by Paperzzz from Crossref and OSF.Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial Nature Communications